Search Within

Chrisann Kyi Kyi

Formats
  1. Journal Article (19)
  2. Meeting Abstract (19)
  3. Research Letter (1)
Groups
  1. Department of Medicine (39)
  2. GDMT, Medicine (39)
  3. Gynecologic Medicine Service (39)
  4. Gynecology Disease Management Team (39)
  5. Solid Tumor Oncology Division (39)
  6. Hematologic Malignancies, Division of (23)

More Groups

People
  1. Roisin O'Cearbhaill (22)
  2. Claire Friedman (21)
  3. Carol Aghajanian (20)
  4. Rachel Grisham (15)
  5. Vicky Makker (15)
  6. Alexia Iasonos (14)

More People

Years
  1. 2025 (4)
  2. 2024 (10)
  3. 2023 (2)
  4. 2022 (8)
  5. 2021 (7)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (12)
  2. Gynecologic Oncology (7)
  3. Journal for ImmunoTherapy of Cancer (4)
  4. Annals of Oncology (3)
  5. International Journal of Gynecological Cancer (3)
  6. Cancer Research (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (12)
  2. Elsevier Inc. (7)
  3. Biomed Central Ltd (4)
  4. American Association for Cancer Research (3)
  5. Lippincott Williams & Wilkins (3)
  6. Oxford University Press (3)

More Publishers

Results (39)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of IDO-inhibitor, BMS-986205 (IDO), and PD-1 inhibitor, nivolumab (NIVO), in recurrent or persistent endometrial cancer (EC; CA017-056)
    Meeting Abstract

    Kyi, C.; Rubinstein, M. M.; Shah, P.; Zhou, Q.; Iasonos, A.; Liu, Y.; Ramirez, L.; Paroder, V.; Green, A.; Friedman, C. F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Basket study of oral progesterone antagonist onapristone extended release (ONA-XR) in progesterone receptor positive (PR+) recurrent granulosa cell (GCT), low-grade serous ovarian (LGSOC), or endometrioid endometrial cancer (EEC)
    Meeting Abstract

    Grisham, R. N.; Li, K.; Zhou, Q.; Iasonos, A.; Girshman, J.; Shah, P.; Jang, D.; Kyi, C.; Cohen, S. M.; O'Cearbhaill, R. E.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Dysfunctional CD8+T cells in the tumor microenvironment are associated with response to nivolumab in mismatch repair deficient (dMMR) or hypermutated ovarian (OVCA) or endometrial cancer (EC)
    Meeting Abstract

    Friedman, C. F.; Zhou, Q.; Iasonos, A.; Holland, A.; Ramirez, L.; Grisham, R. N.; Guo, R.; Lichtman, S. M.; Kyi, C.; Makker, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies
    Journal Article

    Schöffski, P.; Tan, D. S. W.; Martín, M.; Ochoa-de-Olza, M.; Sarantopoulos, J.; Carvajal, R. D.; Kyi, C.; Esaki, T.; Prawira, A.; Akerley, W.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Phase I dose escalation study of MCLA-145, a bispecific antibody targeting CD137 and PD-L1 in solid tumors
    Meeting Abstract

    Prenen, H.; Kyi, C.; Van Lancker, G.; Patel, S. P.; Mittag, D.; Weaver, A.; Bol, K.; Stalbovskaya, V.; Pulini, J.; Zhou, G.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Uterine mesenchymal tumors harboring ALK fusions and response to ALK-targeted therapy
    Journal Article

    Kyi, C.; Friedman, C. F.; Mueller, J. J.; Benayed, R.; Ladanyi, M.; Arcila, M.; Yang, S. R.; Hensley, M. L.; Chiang, S.
    Gynecologic Oncology Reports (2021)

    Fulltext@MSK | Save
  • Phase I dose escalation safety and feasibility study of autologous WT1-sensitized T cells for the treatment of patients with recurrent ovarian cancer
    Journal Article

    Kyi, C.; Doubrovina, E.; Zhou, Q.; Kravetz, S.; Iasonos, A.; Aghajanian, C.; Sabbatini, P.; Spriggs, D.; O'Reilly, R. J.; O'Cearbhaill, R. E.
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Pattern of disease and response to pembrolizumab in recurrent cervical cancer
    Journal Article

    Miller, K. M.; Filippova, O. T.; Hayes, S. A.; Abu-Rustum, N. R.; Aghajanian, C.; Broach, V.; Ellenson, L. H.; Selenica, P.; Jewell, E. L.; Kyi, C.; more...
    Gynecologic Oncology Reports (2021)

    Fulltext@MSK | Save
  • Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial
    Journal Article

    Ferris, R. L.; Spanos, W. C.; Leidner, R.; Gonçalves, A.; Martens, U. M.; Kyi, C.; Sharfman, W.; Chung, C. H.; Devriese, L. A.; Gauthier, H.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Impact of tumor heterogeneity and microenvironment in identifying neoantigens in a patient with ovarian cancer
    Journal Article

    Dao, T.; Klatt, M. G.; Korontsvit, T.; Mun, S. S.; Guzman, S.; Mattar, M.; Zivanovic, O.; Kyi, C. K.; Socci, N. D.; O’Cearbhaill, R. E.; more...
    Cancer Immunology, Immunotherapy (2021)

    Fulltext@MSK | Save